Observational research on chronic diseases and healthcare analytics
OPERA Longitudinal Observational Database in the Study of Chronic Diseases, Treatments and Outcomes
This study looks at health records to see how well different treatments work for chronic diseases like HIV and hepatitis, aiming to improve patient care and support.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000000 (estimated) |
| Ages | 0 Years and up |
| Sex | All |
| Sponsor | Epividian Industry-sponsored |
| Locations | 1 site (Durham, North Carolina) |
| Trial ID | NCT03813862 on ClinicalTrials.gov |
What this trial studies
This study utilizes the OPERA longitudinal database, which collects de-identified electronic health record (EHR) data from various clinical practices to research chronic diseases such as HIV, HCV, and HBV. The aim is to enhance clinical decision support systems and improve patient engagement through sophisticated healthcare analytics. By analyzing real-world data, the study seeks to provide insights into treatment outcomes and quality measures for chronic disease management. The findings will be disseminated through scientific conferences and peer-reviewed journals to inform healthcare practices.
Who should consider this trial
Good fit: Ideal candidates for this study are patients receiving treatment for chronic diseases documented in participating practices' EHR systems.
Not a fit: Patients who opt out of the OPERA program will not benefit from this study.
Why it matters
Potential benefit: If successful, this research could lead to improved management and treatment outcomes for patients with chronic diseases.
How similar studies have performed: Other studies utilizing observational data and EHR systems have shown success in improving patient outcomes and healthcare quality, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who are treated in the practices who enroll and participate in the study * Patients whose treatment is documented in the practice's electronic health record system Exclusion Criteria: * Patients who opt out of OPERA
Where this trial is running
Durham, North Carolina
- Epividian — Durham, North Carolina, United States (Recruiting)
Study contacts
- Study coordinator: Gregory Fusco, MD
- Email: gregory.fusco@epividian.com
- Phone: 224-632-1862
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.